Softgel Capsule Market Summary
As per Market Research Future Analysis, the Softgel Capsule Market was valued at 4.37 USD Billion in 2023 and is projected to grow to 8.5 USD Billion by 2035, with a CAGR of 5.7% from 2025 to 2035. The market is driven by rising demand for dietary supplements and nutraceuticals, advancements in softgel technology, an increasing aging population, and a growing preference for plant-based ingredients. Major companies are focusing on product innovation and expanding their offerings to meet consumer needs.
Key Market Trends & Highlights
Key trends driving the Softgel Capsule Market include:
- The global dietary supplements market is expected to grow from 140 billion USD in 2022 to 245 billion USD by 2024, with a CAGR of about 8%.
- The aging population is projected to double from 703 million in 2019 to 1.5 billion by 2050, increasing demand for health supplements.
- Plant-based food sales increased by 27% from 2018 to 2020, influencing the shift towards plant-based softgel capsules.
- Technological advancements in encapsulation are growing at a rate of 6.5% annually, enhancing product quality and stability.
Market Size & Forecast
| 2023 Market Size | USD 4.37 Billion |
| 2024 Market Size | USD 4.62 Billion |
| 2035 Market Size | USD 8.5 Billion |
| CAGR (2025-2035) | 5.7% |
Major Players
Procaps Group, Nutraceutical Corporation, Ginkgo BioWorks, Capsugel, Qualicaps, Swallow Solutions, Softgel Technologies, Alcami, BASF, Fagron, Heathwest, HPMC Caps, Amgen, Meda Pharmaceuticals
